6.83
前日終値:
$6.70
開ける:
$6.64
24時間の取引高:
3.10M
Relative Volume:
1.16
時価総額:
$2.06B
収益:
$493.67M
当期純損益:
$-104.69M
株価収益率:
-20.09
EPS:
-0.34
ネットキャッシュフロー:
$-31.51M
1週間 パフォーマンス:
+4.92%
1か月 パフォーマンス:
-25.11%
6か月 パフォーマンス:
-42.94%
1年 パフォーマンス:
-35.26%
Amicus Therapeutics Inc Stock (FOLD) Company Profile
名前
Amicus Therapeutics Inc
セクター
電話
(609) 662-2000
住所
47 HULFISH STREET, PRINCETON, NJ
FOLD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
FOLD
Amicus Therapeutics Inc
|
6.83 | 2.06B | 493.67M | -104.69M | -31.51M | -0.34 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-13 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2024-09-06 | 開始されました | Jefferies | Buy |
2024-05-30 | 開始されました | Wells Fargo | Overweight |
2024-05-14 | アップグレード | Guggenheim | Neutral → Buy |
2023-12-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2022-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
2022-04-13 | 再開されました | Goldman | Neutral |
2022-01-14 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
2021-11-15 | アップグレード | Stifel | Hold → Buy |
2021-09-30 | アップグレード | JP Morgan | Neutral → Overweight |
2021-07-19 | 再開されました | BTIG Research | Buy |
2021-05-27 | 開始されました | Needham | Hold |
2021-05-21 | 開始されました | UBS | Buy |
2021-04-14 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
2021-03-02 | 開始されました | Stifel | Hold |
2021-02-12 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2021-02-12 | ダウングレード | JP Morgan | Overweight → Neutral |
2020-12-28 | 再開されました | Cantor Fitzgerald | Overweight |
2020-12-10 | ダウングレード | Citigroup | Buy → Neutral |
2020-11-11 | 開始されました | Berenberg | Hold |
2020-06-17 | 開始されました | BTIG Research | Buy |
2020-02-04 | 再開されました | Cantor Fitzgerald | Overweight |
2019-11-12 | 繰り返されました | H.C. Wainwright | Buy |
2019-06-17 | 開始されました | H.C. Wainwright | Buy |
2019-06-05 | 繰り返されました | Cantor Fitzgerald | Overweight |
2019-04-05 | 開始されました | Janney | Buy |
2019-01-30 | 開始されました | Cantor Fitzgerald | Overweight |
2018-10-29 | 開始されました | Citigroup | Neutral |
2018-08-17 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
2017-10-06 | 再開されました | Goldman | Neutral |
2017-09-13 | 繰り返されました | Chardan Capital Markets | Buy |
2017-08-10 | 繰り返されました | Chardan Capital Markets | Buy |
2017-01-24 | アップグレード | Robert W. Baird | Neutral → Outperform |
2016-05-18 | 開始されました | BofA/Merrill | Buy |
2016-04-14 | 開始されました | Robert W. Baird | Neutral |
2016-04-12 | 繰り返されました | Chardan Capital Markets | Buy |
2015-09-16 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
2015-06-16 | 繰り返されました | Chardan Capital Markets | Buy |
すべてを表示
Amicus Therapeutics Inc (FOLD) 最新ニュース
Granite Investment Partners LLC Purchases 166,657 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Renaissance Technologies LLC Has $19.86 Million Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
4 Healthcare Stocks to Buy as the Sector Faces Government Heat - Yahoo Finance
(FOLD) Proactive Strategies - news.stocktradersdaily.com
Pompe Disease Treatment Market New Product Development & Latest Trends | Sanofi,Amicus Therapeutics,Genzym - openPR.com
Enzyme Replacement Therapy Market Is Booming Worldwide - openPR.com
Amicus Therapeutics (NASDAQ:FOLD) Shares Down 6.3%Should You Sell? - MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Sets New 52-Week LowHere's What Happened - MarketBeat
ExodusPoint Capital Management LP Sells 537,938 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Norges Bank Invests $29.03 Million in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Is Amicus Therapeutics, Inc. (FOLD) the Best Low Priced Growth Stock To Invest In? - Insider Monkey
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Not Doing Enough For Some Investors As Its Shares Slump 27% - simplywall.st
Massachusetts Financial Services Co. MA Grows Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Fabry Disease Treatment Market Opportunity and Forecast Report 2025-2034 Featuring Amicus Therapeutics, Avrobio, Freeline, Idorsia, ISU Abxis, JCR, Novartis, Pfizer, Protalix, Sanofi, Takeda, Viatris - Yahoo Finance
Analysts Expect Amicus Therapeutics, Inc. (NASDAQ:FOLD) To Breakeven Soon - Yahoo Finance
Old West Investment Management LLC Grows Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Vanguard Group Inc. Has $275.62 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
JPMorgan Chase & Co. Reduces Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics stock hits 52-week low at $6.99 By Investing.com - Investing.com South Africa
Amicus Therapeutics stock hits 52-week low at $6.99 - Investing.com
Is Amicus Therapeutics, Inc. (FOLD) the Best Low Cost Stock to Buy According to Billionaires? - Insider Monkey
Research Analysts Issue Forecasts for FOLD Q1 Earnings - MarketBeat
Trexquant Investment LP Acquires 486,827 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
AMICUS STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Amicus Therapeutics, Inc. - Bluefield Daily Telegraph
AMICUS STOCKHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire
Zacks Research Analysts Increase Earnings Estimates for FOLD - MarketBeat
Pictet Asset Management Holding SA Sells 110,241 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
KLP Kapitalforvaltning AS Purchases New Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Reaches New 52-Week LowHere's What Happened - MarketBeat
Wellington Management Group LLP Buys 4,497,950 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Brokerages Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) Target Price at $16.75 - MarketBeat
Relative Strength Alert For Amicus Therapeutics - Nasdaq
Amicus Therapeutics stock hits 52-week low at $8.09 - Investing.com
Amicus Therapeutics stock hits 52-week low at $8.09 By Investing.com - Investing.com Australia
Amicus Therapeutics Inc (FOLD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):